Transplant Diagnostics Market Opportunities by 2020 – 2027

As per the research held by Acumen Research and Consulting, “the global Transplant Diagnostics market anticipated to exceed US$ 5,902.2 Mn by 2027, along with the projected CAGR of 7.4% from 2020 to 2027”.

The global Transplant Diagnostics market research report encompasses qualitative and quantitative data derived from the analysis by experts and research analysts in the respective industry verticals from valid sources with the help of primary and secondary research tools.

Get Sample PDF @ https://www.acumenresearchandconsulting.com/request-sample/1846

The major market factors which are driving, hindering, challenging, or providing opportunities are specifically covered to better understand the market position, Recent market trends and governmental regulation & standards are additionally incorporated.

The research report has majorly profiled market information, DROs, segmentation, regional instance, and competitive landscape. The aforementioned entities further encompass prominent sections according to the need of the respective market. Moreover, regional segmentation includes North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and their respective major countries. The dipper information is profiled in terms of regions for getting recent and expected trends and opportunities in the regional market.

Furthermore, in terms of prominent players, the research report comprises a number of major players that are operating in the global competitive environment and offering advance and value-added products to the consumers. A detailed analysis is executed on these players in terms of the business snapshot, product offerings, financial overview, strategic development, player positioning, and R&D investment. This information is essential for the competitors and those who are planning to enter the market.

In a nutshell, the research report is a completely designed solution for those who are seeking information and available opportunities to take decisions of expansion in the desired market. As well as, the research report is also a value-added solution of the research students to get more specific information associated with the market.

Market participants

The players profiled in the report include BAG Healthcare, Becton, Biofortuna (UK), bioMérieux S.A., Bio-Rad Laboratories, Inc. (US), CareDx (US), Dickinson and Company (US), F. Hoffman-La Roche Ltd. (Switzerland), GenDx (Netherlands), Hologic (US), Illumina, Inc. (US), Immucor, Inc. (US), Luminex Corporation (US), QIAGEN N.V. (Netherlands), Takara Bio, and Thermo Fisher Scientific Inc. (US).

Market segmentation

Market By Product & Service

  • Reagents & Consumables
  • Instruments
  • Software & Services

Market By Technology

Molecular Assay

  • PCR-based Molecular Assay
  • Sequencing-based Molecular Assay

Non-molecular Assay

  • Serological Assay
  • Mixed Lymphocyte Culture Assay

Market By Transplant Type

Solid Organ Transplantation

  • Kidney Transplantation
  • Liver Transplantation
  • Heart Transplantation
  • Lung Transplantation
  • Pancreas Transplantation
  • Other Organ Transplantations

Stem Cell Transplantation

Soft Tissue Transplantation

Bone marrow Transplantation

Market By End User

  • Independent Reference Laboratories
  • Hospitals & Transplant Centers
  • Research Laboratories & Academic Institutes

Market By Geography

North America

  • U.S.
  • Canada

Europe

  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table of content

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Transplant Diagnostics
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Transplant Diagnostics Market By Product & Service
1.2.2.1. Global Transplant Diagnostics Market Revenue and Growth Rate Comparison By Product & Service (2016-2027)
1.2.2.2. Global Transplant Diagnostics Market Revenue Share By Product & Service in 2019
1.2.2.3. Reagents & Consumables
1.2.2.4. Instruments
1.2.2.5. Software & Services
1.2.3. Transplant Diagnostics Market By Technology
1.2.3.1. Global Transplant Diagnostics Market Revenue and Growth Rate Comparison By Technology (2016-2027)
1.2.3.2. Molecular Assay
1.2.3.2.1. PCR-based Molecular Assay
1.2.3.2.2. Sequencing-based Molecular Assay
1.2.3.3. Non-molecular Assay
1.2.3.3.1. Serological Assay
1.2.3.3.2. Mixed Lymphocyte Culture Assay
1.2.4. Transplant Diagnostics Market By Transplant Type
1.2.4.1. Global Transplant Diagnostics Market Revenue and Growth Rate Comparison By Transplant Type (2016-2027)
1.2.4.2. Solid Organ Transplantation
1.2.4.2.1. Kidney Transplantation
1.2.4.2.2. Liver Transplantation
1.2.4.2.3. Heart Transplantation
1.2.4.2.4. Lung Transplantation
1.2.4.2.5. Pancreas Transplantation
1.2.4.2.6. Other Organ Transplantations
1.2.4.3. Stem Cell Transplantation
1.2.4.4. Soft Tissue Transplantation
1.2.4.5. Bone marrow Transplantation
1.2.5. Transplant Diagnostics Market By End User
1.2.5.1. Global Transplant Diagnostics Market Revenue and Growth Rate Comparison By End User (2016-2027)
1.2.5.2. Independent Reference Laboratories
1.2.5.3. Hospitals & Transplant Centers
1.2.5.4. Research Laboratories & Academic Institutes
1.2.6. Transplant Diagnostics Market By Geography
1.2.6.1. Global Transplant Diagnostics Market Revenue and Growth Rate Comparison by Geography (2016-2027)
1.2.6.2. North America Transplant Diagnostics Market Revenue and Growth Rate(2016-2027)
1.2.6.3. Europe Transplant Diagnostics Market Revenue and Growth Rate(2016-2027)
1.2.6.4. Asia-Pacific Transplant Diagnostics Market Revenue and Growth Rate(2016-2027)
1.2.6.5. Latin America Transplant Diagnostics Market Revenue and Growth Rate(2016-2027)
1.2.6.6. Middle East and Africa (MEA) Transplant Diagnostics Market Revenue and Growth Rate(2016-2027)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Transplant Diagnostics Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Transplant Diagnostics Major Manufacturers in 2019
3.3. R&D Status and Technology Source of Global Transplant Diagnostics Major Manufacturers in 2019
3.4. Raw Materials Sources Analysis of Global Transplant Diagnostics Major Manufacturers in 2019

CHAPTER 4. TRANSPLANT DIAGNOSTICS MARKET BY PRODUCT & SERVICE
4.1. Global Transplant Diagnostics Revenue By Product & Service
4.2. Reagents & Consumables
4.2.1. Market Revenue and Growth Rate, 2016 – 2027 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2016 – 2027 ($Million)
4.3. Instruments
4.3.1. Market Revenue and Growth Rate, 2016 – 2027 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2016 – 2027 ($Million)
4.4. Software & Services
4.4.1. Market Revenue and Growth Rate, 2016 – 2027 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2016 – 2027 ($Million)

CHAPTER 5. TRANSPLANT DIAGNOSTICS MARKET BY TECHNOLOGY
5.1. Global Transplant Diagnostics Revenue By Technology
5.2. Molecular Assay
5.2.1. Market Revenue and Growth Rate, 2016 – 2027 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2016 – 2027 ($Million)
5.2.3. PCR-based Molecular Assay
5.2.4. Sequencing-based Molecular Assay
5.3. Non-molecular Assay
5.3.1. Market Revenue and Growth Rate, 2016 – 2027 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2016 – 2027 ($Million)
5.3.3. Serological Assay
5.3.4. Mixed Lymphocyte Culture Assay

CHAPTER 6. TRANSPLANT DIAGNOSTICS MARKET BY TRANSPLANT TYPE
6.1. Global Transplant Diagnostics Revenue By Transplant Type
6.2. Solid Organ Transplantation
6.2.1. Market Revenue and Growth Rate, 2016 – 2027 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2016 – 2027 ($Million)
6.2.3. Kidney Transplantation
6.2.4. Liver Transplantation
6.2.5. Heart Transplantation
6.2.6. Lung Transplantation
6.2.7. Pancreas Transplantation
6.2.8. Other Organ Transplantations
6.3. Stem Cell Transplantation
6.3.1. Market Revenue and Growth Rate, 2016 – 2027 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2016 – 2027 ($Million)
6.4. Soft Tissue Transplantation
6.4.1. Market Revenue and Growth Rate, 2016 – 2027 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2016 – 2027 ($Million)
6.5. Bone marrow Transplantation
6.5.1. Market Revenue and Growth Rate, 2016 – 2027 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2016 – 2027 ($Million)

CHAPTER 7. TRANSPLANT DIAGNOSTICS MARKET BY END USER
7.1. Global Transplant Diagnostics Revenue By End User
7.2. Independent Reference Laboratories
7.2.1. Market Revenue and Growth Rate, 2016 – 2027 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2016 – 2027 ($Million)
7.3. Hospitals & Transplant Centers
7.3.1. Market Revenue and Growth Rate, 2016 – 2027 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2016 – 2027 ($Million)
7.4. Research Laboratories & Academic Institutes
7.4.1. Market Revenue and Growth Rate, 2016 – 2027 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2016 – 2027 ($Million)

CHAPTER 8. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET BY COUNTRY
8.1. North America Transplant Diagnostics Market Revenue and Growth Rate, 2016 – 2027 ($Million)
8.2. North America Transplant Diagnostics Market Revenue Share Comparison, 2016 & 2027 (%)
8.3. U.S.
8.3.1. U.S. Transplant Diagnostics Market Revenue and Forecast By Product & Service, 2016 – 2027 ($Million)
8.3.2. Market Revenue and Forecast By Technology, 2016 – 2027 ($Million)
8.3.3. Market Revenue and Forecast By Transplant Type, 2016 – 2027 ($Million)
8.3.4. Market Revenue and Forecast By End User, 2016 – 2027 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Product & Service, 2016 – 2027 ($Million)
8.4.2. Market Revenue and Forecast By Technology, 2016 – 2027 ($Million)
8.4.3. Market Revenue and Forecast By Transplant Type, 2016 – 2027 ($Million)
8.4.4. Market Revenue and Forecast By End User, 2016 – 2027 ($Million)

CHAPTER 9. EUROPE TRANSPLANT DIAGNOSTICS MARKET BY COUNTRY
9.1. Europe Transplant Diagnostics Market Revenue and Growth Rate, 2016 – 2027 ($Million)
9.2. Europe Transplant Diagnostics Market Revenue Share Comparison, 2016 & 2027 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Product & Service, 2016 – 2027 ($Million)
9.3.2. Market Revenue and Forecast By Technology, 2016 – 2027 ($Million)
9.3.3. Market Revenue and Forecast By Transplant Type, 2016 – 2027 ($Million)
9.3.4. Market Revenue and Forecast By End User, 2016 – 2027 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Product & Service, 2016 – 2027 ($Million)
9.4.2. Market Revenue and Forecast By Technology, 2016 – 2027 ($Million)
9.4.3. Market Revenue and Forecast By Transplant Type, 2016 – 2027 ($Million)
9.4.4. Market Revenue and Forecast By End User, 2016 – 2027 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Product & Service, 2016 – 2027 ($Million)
9.5.2. Market Revenue and Forecast By Technology, 2016 – 2027 ($Million)
9.5.3. Market Revenue and Forecast By Transplant Type, 2016 – 2027 ($Million)
9.5.4. Market Revenue and Forecast By End User, 2016 – 2027 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Product & Service, 2016 – 2027 ($Million)
9.6.2. Market Revenue and Forecast By Technology, 2016 – 2027 ($Million)
9.6.3. Market Revenue and Forecast By Transplant Type, 2016 – 2027 ($Million)
9.6.4. Market Revenue and Forecast By End User, 2016 – 2027 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Product & Service, 2016 – 2027 ($Million)
9.7.2. Market Revenue and Forecast By Technology, 2016 – 2027 ($Million)
9.7.3. Market Revenue and Forecast By Transplant Type, 2016 – 2027 ($Million)
9.7.4. Market Revenue and Forecast By End User, 2016 – 2027 ($Million)

CHAPTER 10. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET BY COUNTRY
10.1. Asia-Pacific Transplant Diagnostics Market Revenue and Growth Rate, 2016 – 2027 ($Million)
10.2. Asia-Pacific Transplant Diagnostics Market Revenue Share Comparison, 2016 & 2027 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Product & Service, 2016 – 2027 ($Million)
10.3.2. Market Revenue and Forecast By Technology, 2016 – 2027 ($Million)
10.3.3. Market Revenue and Forecast By Transplant Type, 2016 – 2027 ($Million)
10.3.4. Market Revenue and Forecast By End User, 2016 – 2027 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Product & Service, 2016 – 2027 ($Million)
10.4.2. Market Revenue and Forecast By Technology, 2016 – 2027 ($Million)
10.4.3. Market Revenue and Forecast By Transplant Type, 2016 – 2027 ($Million)
10.4.4. Market Revenue and Forecast By End User, 2016 – 2027 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Product & Service, 2016 – 2027 ($Million)
10.5.2. Market Revenue and Forecast By Technology, 2016 – 2027 ($Million)
10.5.3. Market Revenue and Forecast By Transplant Type, 2016 – 2027 ($Million)
10.5.4. Market Revenue and Forecast By End User, 2016 – 2027 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Product & Service, 2016 – 2027 ($Million)
10.6.2. Market Revenue and Forecast By Technology, 2016 – 2027 ($Million)
10.6.3. Market Revenue and Forecast By Transplant Type, 2016 – 2027 ($Million)
10.6.4. Market Revenue and Forecast By End User, 2016 – 2027 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Product & Service, 2016 – 2027 ($Million)
10.7.2. Market Revenue and Forecast By Technology, 2016 – 2027 ($Million)
10.7.3. Market Revenue and Forecast By Transplant Type, 2016 – 2027 ($Million)
10.7.4. Market Revenue and Forecast By End User, 2016 – 2027 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Product & Service, 2016 – 2027 ($Million)
10.8.2. Market Revenue and Forecast By Technology, 2016 – 2027 ($Million)
10.8.3. Market Revenue and Forecast By Transplant Type, 2016 – 2027 ($Million)
10.8.4. Market Revenue and Forecast By End User, 2016 – 2027 ($Million)

CHAPTER 11. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET BY COUNTRY
11.1. Latin America Transplant Diagnostics Market Revenue and Growth Rate, 2016 – 2027 ($Million)
11.2. Latin America Transplant Diagnostics Market Revenue Share Comparison, 2016 & 2027 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Product & Service, 2016 – 2027 ($Million)
11.3.2. Market Revenue and Forecast By Technology, 2016 – 2027 ($Million)
11.3.3. Market Revenue and Forecast By Transplant Type, 2016 – 2027 ($Million)
11.3.4. Market Revenue and Forecast By End User, 2016 – 2027 ($Million)
11.4. Mexico
11.4.1. Market Revenue and Forecast By Product & Service, 2016 – 2027 ($Million)
11.4.2. Market Revenue and Forecast By Technology, 2016 – 2027 ($Million)
11.4.3. Market Revenue and Forecast By Transplant Type, 2016 – 2027 ($Million)
11.4.4. Market Revenue and Forecast By End User, 2016 – 2027 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Product & Service, 2016 – 2027 ($Million)
11.5.2. Market Revenue and Forecast By Technology, 2016 – 2027 ($Million)
11.5.3. Market Revenue and Forecast By Transplant Type, 2016 – 2027 ($Million)
11.5.4. Market Revenue and Forecast By End User, 2016 – 2027 ($Million)

CHAPTER 12. MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET BY COUNTRY
12.1. Middle East & Africa Transplant Diagnostics Market Revenue and Growth Rate, 2016 – 2027 ($Million)
12.2. Middle East & Africa Transplant Diagnostics Market Revenue Share Comparison, 2016 & 2027 (%)
12.3. GCC
12.3.1. Market Revenue and Forecast By Product & Service, 2016 – 2027 ($Million)
12.3.2. Market Revenue and Forecast By Technology, 2016 – 2027 ($Million)
12.3.3. Market Revenue and Forecast By Transplant Type, 2016 – 2027 ($Million)
12.3.4. Market Revenue and Forecast By End User, 2016 – 2027 ($Million)
12.4. South Africa
12.4.1. Market Revenue and Forecast By Product & Service, 2016 – 2027 ($Million)
12.4.2. Market Revenue and Forecast By Technology, 2016 – 2027 ($Million)
12.4.3. Market Revenue and Forecast By Transplant Type, 2016 – 2027 ($Million)
12.4.4. Market Revenue and Forecast By End User, 2016 – 2027 ($Million)
12.5. Rest of Middle East & Africa
12.5.1. Market Revenue and Forecast By Product & Service, 2016 – 2027 ($Million)
12.5.2. Market Revenue and Forecast By Technology, 2016 – 2027 ($Million)
12.5.3. Market Revenue and Forecast By Transplant Type, 2016 – 2027 ($Million)
12.5.4. Market Revenue and Forecast By End User, 2016 – 2027 ($Million)

CHAPTER 13. COMPANY PROFILE
13.1. BAG Healthcare
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Becton
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Biofortuna (UK)
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. bioMérieux S.A.
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Bio-Rad Laboratories, Inc. (US)
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. CareDx (US)
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Dickinson and Company (US)
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. F. Hoffman-La Roche Ltd. (Switzerland)
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. GenDx (Netherlands)
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Others
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies

CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

Buy this premium report @ https://www.acumenresearchandconsulting.com/buy-now/0/1846

Contact us:

Sheetal k

Email: sales@acumenresearchandconsulting.com

Phone: +14079154157 | +14089009135

Website: https://www.acumenresearchandconsulting.com